MS medications and a third dose of the COVID-19 vaccine

Last updated: 03/11/2021
Last reviewed: 03/11/2021

MS medications and a third dose of the COVID-19 vaccine for individuals who are potentially immunocompromised

Below is a list of medications and their current associated recommendations regarding a third dose.

Forms of MS used for: Relapsing remitting MS.

Recommendations for 3rd COVID-19 dose: This medication is not expected to affect the immune response to vaccines and a 3rd dose is currently not recommended at present.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not expected to affect the immune response to vaccines and a 3rd dose is currently not recommended at present.

Forms of MS used for: All forms of MS.

Recommendation for 3rd COVID-19 dose: This medication is not expected to affect the immune response to vaccines and a 3rd dose is currently not recommended at present.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication may affect the immune response to vaccines and a 3rd dose is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI).

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication may affect the immune response to vaccines and a 3rd dose is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI).

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication may affect the immune response to vaccines and a 3rd dose is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI).

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not currently listed in the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines and a 3rd dose is currently not recommended.

Forms of MS used for: Secondary progressive MS.

Recommendation for 3rd COVID-19 dose: This medication may affect the immune response to vaccines and a 3rd dose is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI).

Forms of MS used for: Relapsing remitting MS and primary progressive MS.

Recommendation for 3rd COVID-19 dose: This medication may affect the immune response to vaccines and a 3rd dose is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI).

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not expected to affect the immune response to vaccines and a 3rd dose is currently not recommended at present.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not expected to affect the immune response to vaccines and a 3rd dose is not recommended at present.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not currently listed in the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines and a 3rd dose is currently not recommended.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not currently listed in the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines and a 3rd dose is currently not recommended.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication is not currently listed in the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines and a 3rd dose is currently not recommended.

Forms of MS used for: Relapsing remitting MS.

Recommendation for 3rd COVID-19 dose: This medication may affect the immune response to vaccines and a 3rd dose is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI).

Helpful Hotlines:

State and territory MS organisations:

Read More

Newsletter subscription

  • Enter your details

MS medications and a third booster dose of COVID-19 vaccine